Effects of intervention therapy of methylcobalamin and folic acid on plasma homocysteine concentration and homocysteine thiolactonase/paraoxonase activity in patients with type 2 diabetes mellitus

National Medical Journal of China

Volumn 87, Issue 4, 2007, Pages 256-258

  Gu, Wei Jun ^a   Lu, Ju Ming ^a   Yang, Gou Qing ^a   Guo, Qing Hua ^a   Dou, Jing Tao ^a   Mu, Yi Ming ^a   Pan, Chang Yu ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Cysteine; Diabetes mellitus; Folic acid; Methylcobalamin

Indexed keywords

ARYLDIALKYLPHOSPHATASE; CYANOCOBALAMIN; ENZYME; FOLIC ACID; HOMOCYSTEINE; HOMOCYSTEINE THIOLACTONASE; MECOBALAMIN; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FOLIC ACID BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; VITAMIN BLOOD LEVEL;

ADMINISTRATION, ORAL; ADULT; AGED; ARYLDIALKYLPHOSPHATASE; CARBOXYLIC ESTER HYDROLASES; DIABETES MELLITUS, TYPE 2; DRUG THERAPY, COMBINATION; FOLIC ACID; HOMOCYSTEINE; HUMANS; INJECTIONS, INTRAMUSCULAR; MIDDLE AGED; TREATMENT OUTCOME; VITAMIN B 12; VITAMIN B COMPLEX;

EID: 33947167261     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Elkhairy L, Ueland PM, Refsum H, et al. Plasma total cysteine as a risk factor for vascular disease: the European Concerted Action Project. Circulation,2001,103:2544-2549.
2. Hoogeveen EK, Kostense PJ, Berks PJ, et al. Hyperhomocysteinemia is associated with an increase risk of cardiovascular disease, especially in noninsulin dependent diabetes mellitus: a population based study. Arterioscler Thromb Vasc Biol,1998,18:133-138.
3. Chinese source.
4. Chinese source.
5. Nygard O, Nordrehaud JE, Refsum H, et al. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med, 1997, 337:230-236.
6. Selhub J, Jacques PF, Wilson PWF, et al. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA, 1993,270:2693-2698.
7. Janel N, Robert K, Chabert C, et al. Mouse liver paraoxonase-1 gene expressionis downregulated in hyperhomocysteinemia. Thromb Haemost,2004,92:221-222.
8. Mecknenss B, Durrington PN, Mackness MI, et al. Paraoxonase and coronary heart disease. Curr Opin Lipidol, 1998, 119: 319-324.
9. Blundell G, Jones BG, Rose FA, et al. Homocysteine mediated endothelial cell toxicity and its amelioration. Atherosclerosis, 1996,122:163-172.
10. Huang SR, Hsu Y, Lin HL, et al. Folate depletion and elevated plasma homocysteine promote oxidative stress in rat livers. J Nutr, 2001,131:33-38.